Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
Valkyrie Clinical Trials, Los Angeles, California SCRI Denver DDU at HealthOne, Denver, Colorado Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania SCRI Oncology Partners, Nashville, Tennessee